Published in Br J Surg on October 01, 1998
Intercostobrachial Nerve Sparing to Reduce Post-Surgical Pain (INSPIRE) | NCT03421522
The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer (2008) 1.10
Anatomical variations of the axilla. Springerplus (2014) 0.94
Predictors of persistent pain after breast cancer surgery: a systematic review and meta-analysis of observational studies. CMAJ (2016) 0.81
The prefixed and postfixed brachial plexus: a review with surgical implications. Surg Radiol Anat (2010) 0.80
Persistent Pain after Breast Cancer Treatment: A Questionnaire-Based Study on the Prevalence, Associated Treatment Variables, and Pain Type. J Breast Cancer (2016) 0.78
Phantom breast syndrome. Indian J Palliat Care (2009) 0.76
Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer. Br J Surg (1999) 0.75
Peripheral communications of intercostobrachial nerve Peripheral communications of the intercostobrachial nerve in relation to the alar thoracic artery. Adv Biomed Res (2015) 0.75
Intercellular Connection between Smooth Muscle Cells: the Nexus. Science (1962) 6.27
COMPLEMENT IN INFECTIOUS DISEASE IN MAN. J Clin Invest (1946) 2.75
Randomised controlled trial of effects of early discharge after surgery for breast cancer. BMJ (1998) 2.58
Electrical transmission at the nexus between smooth muscle cells. J Gen Physiol (1968) 2.54
Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia. Lancet (1992) 2.17
1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res (2000) 2.01
Mastectomies of healthy, contralateral breasts in patients with breast cancer. Br J Hosp Med (Lond) (2013) 2.00
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
The resistance of the septum of the median giant axon of the earthworm. J Gen Physiol (1977) 1.71
COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer (2004) 1.59
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Cholecystectomy: a study of patient satisfaction. J R Coll Surg Edinb (1993) 1.55
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Ann Oncol (2011) 1.51
Can preoperative factors predict for residual malignancy after breast biopsy for invasive cancer? Ann R Coll Surg Engl (1995) 1.47
ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression. Int J Cancer (2001) 1.46
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
A measurement of the ability to drive after different types of inguinal hernia repair. Surg Laparosc Endosc (1998) 1.40
Lymphocytic mastopathy associated with ductal carcinoma in situ of the breast. Histopathology (1995) 1.38
Propagation in vertebrate visceral smooth muscle. J Theor Biol (1963) 1.28
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients. Cancer Epidemiol Biomarkers Prev (2001) 1.27
Electrical characteristics of frog atrial trabeculae in the double sucrose gap. Biophys J (1975) 1.20
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer (2006) 1.18
Localization of rhodopsin antibody in the retina of the frog. J Mol Biol (1969) 1.15
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence. Br J Cancer (2006) 1.13
Hidden dangers of sliced bread. Br Med J (Clin Res Ed) (1984) 1.12
Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet (2008) 1.12
Treatment of extremity soft tissue sarcomas with surgery and radiotherapy. Radiother Oncol (1990) 1.12
Management of obstructed balloon catheters. Br Med J (Clin Res Ed) (1984) 1.10
Prognostic significance of oestrogen and progestogen receptor activities in breast cancer. Br J Surg (1987) 1.07
Prognostic implications of perineural spread in squamous carcinomas of the head and neck. Laryngoscope (1986) 1.04
A drip is unnecessary after cholecystectomy. J R Coll Surg Edinb (1992) 1.03
Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. BMJ (1996) 1.03
Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer. Br J Cancer (2007) 1.01
Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast. Br J Cancer (1998) 1.00
The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Br J Cancer (2003) 1.00
An equivalent circuit for small atrial trabeculae of frog. Biophys J (1975) 0.99
Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst (2000) 0.98
The role of Robertson's cooked-meat broth in the bacteriological evaluation of surgical specimens. J Med Microbiol (1985) 0.97
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer (1987) 0.97
Carcinoma of the breast presenting as a thyroid mass. Eur J Surg (1997) 0.96
Parathyroid hormone-related protein as a tumour marker in humoral hypercalcaemia associated with occult malignancy. Postgrad Med J (1993) 0.95
Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer. Int J Oncol (2007) 0.95
Screening younger women with a family history of breast cancer--does early detection improve outcome? Eur J Cancer (2006) 0.94
Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr (1998) 0.94
Use of rubber membranes to improve sucrose-gap and other electrical recording techniques. J Appl Physiol (1969) 0.94
Are the lesions of duct ectasia sterile? Br J Surg (1985) 0.94
Cost minimisation analysis of using acellular dermal matrix (Strattice™) for breast reconstruction compared with standard techniques. Eur J Surg Oncol (2012) 0.94
Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med J (1995) 0.94
Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer (2001) 0.94
Further evidence for the selective disruption of intercellular communication by heptanol. Am J Physiol (1999) 0.93
Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas. Cancer (1983) 0.93
Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ. Br J Surg (2005) 0.93
Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response. Blood Coagul Fibrinolysis (2002) 0.92
Polyamines in breast cancer. Br J Surg (1984) 0.92
Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery. Br J Surg (2003) 0.92
Electrical transmission between the cells of vertebrate cardiac muscle. Experientia Suppl (1969) 0.92
Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model of metastasis. Int J Cancer (1997) 0.91
Periductal inflammation and cigarette smoke. J Am Coll Surg (1994) 0.91
Management of accessory breast tissue in the axilla. Br J Surg (2003) 0.91
Gastric surgery and the risk of subsequent colorectal cancer. Br J Surg (1985) 0.90
Effects of a pure antiestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ. Cancer Res (2000) 0.90
Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? Cancer Treat Rev (2012) 0.89
The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer (1998) 0.89
Solvent-Solute Interactions within the Nexal Membrane. Biophys J (1984) 0.89
Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment. Cancer Res (1987) 0.89
Serum vascular endothelial growth factor in breast cancer. Anticancer Res (2007) 0.89
Long term results of a randomised prospective study of preservation of the intercostobrachial nerve. Eur J Surg Oncol (2003) 0.89
Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics. Br J Cancer (2001) 0.88
Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation. Br J Surg (2001) 0.88
Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer. Br J Cancer (1987) 0.88
Mammillary fistula. Br J Surg (1987) 0.88
Expression of parathyroid hormone-related protein and its receptor in bone metastases from prostate cancer. J Pathol (2000) 0.87
Prevention of venous thromboembolism in surgical patients with breast cancer. Br J Surg (2007) 0.87
Expression of the receptor for parathyroid hormone-related protein in normal and malignant breast tissue. J Pathol (1997) 0.87
Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg (1995) 0.87
Bone metastasis in breast cancer: the role of parathyroid hormone related protein. Surg Oncol (1999) 0.87
Surgical decisions made by 158 women with hereditary breast cancer aged <50 years. Eur J Surg Oncol (2005) 0.86
Breast macrocysts. World J Surg (1990) 0.86
Paget's disease of the nipple occurring after wide local excision and radiotherapy for carcinoma of the breast. Eur J Surg Oncol (1989) 0.86
Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia. J Pathol (1993) 0.86
Treatment of the axilla in patients with screen-detected breast cancer. Br J Surg (1993) 0.85
An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha 2 glycoprotein. Histopathology (1987) 0.85
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Cardiol (2001) 0.85
Alteration in platelet function in patients with early breast cancer. Anticancer Res (2005) 0.84